DEANNA LIMBURG: Open Payments
NPI 1063053239 · LONGVIEW, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,791 in 119 payments from 10 companies in 2025. Trend: 2023 $2,248 · 2024 $2,130 · 2025 $1,791
Food & beverage: $1,578Education: $213
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 22 | $417 |
| Vanda Pharmaceuticals Inc. | 23 | $384 |
| ABBVIE INC. | 18 | $238 |
| Alkermes, Inc. | 21 | $218 |
| E.R. Squibb & Sons, L.L.C. | 19 | $216 |
| Neurocrine BioSciences, Inc. | 6 | $137 |
| Otsuka America Pharmaceutical, Inc. | 4 | $83 |
| Luye Pharma (USA) Ltd. | 2 | $39 |
| Axsome Therapeutics, Inc. | 2 | $33 |
| Lundbeck LLC | 2 | $28 |
Products named: FANAPT, VRAYLAR, COBENFY, ARISTADA, INGREZZA, UZEDY, AUSTEDO XR, REXULTI.
Industry payments across TX — which companies pay providers there.
